TrialCancer medicine2023

A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects.

Zev M Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.